Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Vázquez-Martín A[au]:

Autophagy in stem cells. Guan JL et al. Autophagy. (2013)

Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate. Vazquez-Martin A et al. Aging (Albany NY). (2016)

Nucleolar aggresomes mediate release of pericentric heterochromatin and nuclear destruction of genotoxically treated cancer cells. Salmina K et al. Nucleus. (2017)

Search results

Items: 1 to 50 of 113

1.

Nucleolar aggresomes mediate release of pericentric heterochromatin and nuclear destruction of genotoxically treated cancer cells.

Salmina K, Huna A, Inashkina I, Belyayev A, Krigerts J, Pastova L, Vazquez-Martin A, Erenpreisa J.

Nucleus. 2017 Mar 4;8(2):205-221. doi: 10.1080/19491034.2017.1279775. Epub 2017 Jan 9.

2.

Somatic polyploidy is associated with the upregulation of c-MYC interacting genes and EMT-like signature.

Vazquez-Martin A, Anatskaya OV, Giuliani A, Erenpreisa J, Huang S, Salmina K, Inashkina I, Huna A, Nikolsky NN, Vinogradov AE.

Oncotarget. 2016 Nov 15;7(46):75235-75260. doi: 10.18632/oncotarget.12118.

3.

Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate.

Vazquez-Martin A, Van den Haute C, Cufí S, Corominas-Faja B, Cuyàs E, Lopez-Bonet E, Rodriguez-Gallego E, Fernández-Arroyo S, Joven J, Baekelandt V, Menendez JA.

Aging (Albany NY). 2016 Jul;8(7):1330-52. doi: 10.18632/aging.100976.

4.

Role of stress-activated OCT4A in the cell fate decisions of embryonal carcinoma cells treated with etoposide.

Huna A, Salmina K, Erenpreisa J, Vazquez-Martin A, Krigerts J, Inashkina I, Gerashchenko BI, Townsend PA, Cragg MS, Jackson TR.

Cell Cycle. 2015;14(18):2969-84. doi: 10.1080/15384101.2015.1056948. Epub 2015 Jun 23.

5.

The "virgin birth", polyploidy, and the origin of cancer.

Erenpreisa J, Salmina K, Huna A, Jackson TR, Vazquez-Martin A, Cragg MS.

Oncoscience. 2014 Dec 17;2(1):3-14. eCollection 2015. Review.

6.

Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.

Oliveras-Ferraros C, Vazquez-Martin A, Cuyàs E, Corominas-Faja B, Rodríguez-Gallego E, Fernández-Arroyo S, Martin-Castillo B, Joven J, Menendez JA.

Cell Cycle. 2014;13(7):1132-44. doi: 10.4161/cc.27982. Epub 2014 Feb 7.

7.

Ubiquitous transgenic overexpression of C-C chemokine ligand 2: a model to assess the combined effect of high energy intake and continuous low-grade inflammation.

Rodríguez-Gallego E, Riera-Borrull M, Hernández-Aguilera A, Mariné-Casadó R, Rull A, Beltrán-Debón R, Luciano-Mateo F, Menendez JA, Vazquez-Martin A, Sirvent JJ, Martín-Paredero V, Corbí AL, Sierra-Filardi E, Aragonès G, García-Heredia A, Camps J, Alonso-Villaverde C, Joven J.

Mediators Inflamm. 2013;2013:953841. doi: 10.1155/2013/953841. Epub 2013 Dec 15.

8.

Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin.

Manuel Iglesias J, Beloqui I, Garcia-Garcia F, Leis O, Vazquez-Martin A, Eguiara A, Cufi S, Pavon A, Menendez JA, Dopazo J, Martin AG.

PLoS One. 2013 Oct 4;8(10):e77281. doi: 10.1371/journal.pone.0077281. eCollection 2013.

9.

Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.

Vazquez-Martin A, Cufí S, López-Bonet E, Corominas-Faja B, Cuyàs E, Vellon L, Iglesias JM, Leis O, Martín AG, Menendez JA.

Cell Cycle. 2013 Nov 15;12(22):3471-7. doi: 10.4161/cc.26692. Epub 2013 Oct 4.

10.

IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations.

Vazquez-Martin A, Cufí S, Oliveras-Ferraros C, Torres-Garcia VZ, Corominas-Faja B, Cuyàs E, Bonavia R, Visa J, Martin-Castillo B, Barrajón-Catalán E, Micol V, Bosch-Barrera J, Menendez JA.

Sci Rep. 2013;3:2560. doi: 10.1038/srep02560.

11.

Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.

Corominas-Faja B, Cufí S, Oliveras-Ferraros C, Cuyàs E, López-Bonet E, Lupu R, Alarcón T, Vellon L, Iglesias JM, Leis O, Martín ÁG, Vazquez-Martin A, Menendez JA.

Cell Cycle. 2013 Sep 15;12(18):3109-24. doi: 10.4161/cc.26173. Epub 2013 Aug 21.

12.

The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancer.

Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Corominas-Faja B, Cuyàs E, López-Bonet E, Martin-Castillo B, Joven J, Menendez JA.

Sci Rep. 2013;3:2469. doi: 10.1038/srep02469.

13.

Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo.

Cufí S, Bonavia R, Vazquez-Martin A, Oliveras-Ferraros C, Corominas-Faja B, Cuyàs E, Martin-Castillo B, Barrajón-Catalán E, Visa J, Segura-Carretero A, Joven J, Bosch-Barrera J, Micol V, Menendez JA.

Sci Rep. 2013;3:2459. doi: 10.1038/srep02459.

14.

Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.

Cufí S, Bonavia R, Vazquez-Martin A, Corominas-Faja B, Oliveras-Ferraros C, Cuyàs E, Martin-Castillo B, Barrajón-Catalán E, Visa J, Segura-Carretero A, Bosch-Barrera J, Joven J, Micol V, Menendez JA.

Food Chem Toxicol. 2013 Oct;60:360-8. doi: 10.1016/j.fct.2013.07.063. Epub 2013 Aug 1.

PMID:
23916468
15.

Serine79-phosphorylated acetyl-CoA carboxylase, a downstream target of AMPK, localizes to the mitotic spindle poles and the cytokinesis furrow.

Vazquez-Martin A, Corominas-Faja B, Oliveras-Ferraros C, Cufí S, Dalla Venezia N, Menendez JA.

Cell Cycle. 2013 May 15;12(10):1639-41. doi: 10.4161/cc.24700. Epub 2013 Apr 19. No abstract available.

16.

The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells.

Menendez JA, Joven J, Cufí S, Corominas-Faja B, Oliveras-Ferraros C, Cuyàs E, Martin-Castillo B, López-Bonet E, Alarcón T, Vazquez-Martin A.

Cell Cycle. 2013 Apr 15;12(8):1166-79. doi: 10.4161/cc.24479. Epub 2013 Apr 2.

17.

Autophagy in stem cells.

Guan JL, Simon AK, Prescott M, Menendez JA, Liu F, Wang F, Wang C, Wolvetang E, Vazquez-Martin A, Zhang J.

Autophagy. 2013 Jun 1;9(6):830-49. doi: 10.4161/auto.24132. Epub 2013 Mar 13. Review.

18.

Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents.

Menendez JA, Joven J, Aragonès G, Barrajón-Catalán E, Beltrán-Debón R, Borrás-Linares I, Camps J, Corominas-Faja B, Cufí S, Fernández-Arroyo S, Garcia-Heredia A, Hernández-Aguilera A, Herranz-López M, Jiménez-Sánchez C, López-Bonet E, Lozano-Sánchez J, Luciano-Mateo F, Martin-Castillo B, Martin-Paredero V, Pérez-Sánchez A, Oliveras-Ferraros C, Riera-Borrull M, Rodríguez-Gallego E, Quirantes-Piné R, Rull A, Tomás-Menor L, Vazquez-Martin A, Alonso-Villaverde C, Micol V, Segura-Carretero A.

Cell Cycle. 2013 Feb 15;12(4):555-78. doi: 10.4161/cc.23756. Epub 2013 Jan 31.

19.

Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment.

Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Corominas-Faja B, Urruticoechea A, Martin-Castillo B, Menendez JA.

Oncotarget. 2012 Dec;3(12):1600-14.

20.

The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.

Vazquez-Martin A, Corominas-Faja B, Cufi S, Vellon L, Oliveras-Ferraros C, Menendez OJ, Joven J, Lupu R, Menendez JA.

Cell Cycle. 2013 Jan 15;12(2):207-18. doi: 10.4161/cc.23352. Epub 2012 Jan 15. Review.

21.

Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).

Martin-Castillo B, Oliveras-Ferraros C, Vazquez-Martin A, Cufí S, Moreno JM, Corominas-Faja B, Urruticoechea A, Martín ÁG, López-Bonet E, Menendez JA.

Cell Cycle. 2013 Jan 15;12(2):225-45. doi: 10.4161/cc.23274. Epub 2012 Jan 15.

22.

Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency.

Vazquez-Martin A, Cufi S, Lopez-Bonet E, Corominas-Faja B, Oliveras-Ferraros C, Martin-Castillo B, Menendez JA.

Sci Rep. 2012;2:964. doi: 10.1038/srep00964. Epub 2012 Dec 12.

23.

Ser2481-autophosphorylated mTOR colocalizes with chromosomal passenger proteins during mammalian cell cytokinesis.

Vazquez-Martin A, Sauri-Nadal T, Menendez OJ, Oliveras-Ferraros C, Cufí S, Corominas-Faja B, López-Bonet E, Menendez JA.

Cell Cycle. 2012 Nov 15;11(22):4211-21. doi: 10.4161/cc.22551. Epub 2012 Oct 24.

24.

Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).

Oliveras-Ferraros C, Corominas-Faja B, Cufí S, Vazquez-Martin A, Martin-Castillo B, Iglesias JM, López-Bonet E, Martin ÁG, Menendez JA.

Cell Cycle. 2012 Nov 1;11(21):4020-32. doi: 10.4161/cc.22225. Epub 2012 Sep 19.

25.

Rejuvenating regeneration: metformin activates endogenous adult stem cells.

Menendez JA, Vazquez-Martin A.

Cell Cycle. 2012 Oct 1;11(19):3521-2. doi: 10.4161/cc.21878. Epub 2012 Aug 30. No abstract available.

26.

Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs.

Corominas-Faja B, Quirantes-Piné R, Oliveras-Ferraros C, Vazquez-Martin A, Cufí S, Martin-Castillo B, Micol V, Joven J, Segura-Carretero A, Menendez JA.

Aging (Albany NY). 2012 Jul;4(7):480-98.

27.

Metformin is synthetically lethal with glucose withdrawal in cancer cells.

Menendez JA, Oliveras-Ferraros C, Cufí S, Corominas-Faja B, Joven J, Martin-Castillo B, Vazquez-Martin A.

Cell Cycle. 2012 Aug 1;11(15):2782-92. doi: 10.4161/cc.20948. Epub 2012 Aug 1.

PMID:
22809961
28.

Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: new insight into the role of mitophagy in cell stemness.

Vazquez-Martin A, Cufi S, Corominas-Faja B, Oliveras-Ferraros C, Vellon L, Menendez JA.

Aging (Albany NY). 2012 Jun;4(6):393-401.

29.

Polo-like kinase 1 directs the AMPK-mediated activation of myosin regulatory light chain at the cytokinetic cleavage furrow independently of energy balance.

Vazquez-Martin A, Cufí S, Oliveras-Ferraros C, Menendez JA.

Cell Cycle. 2012 Jul 1;11(13):2422-6. doi: 10.4161/cc.20438. Epub 2012 Jul 1.

PMID:
22672936
30.

Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.

Cufi S, Corominas-Faja B, Vazquez-Martin A, Oliveras-Ferraros C, Dorca J, Bosch-Barrera J, Martin-Castillo B, Menendez JA.

Oncotarget. 2012 Apr;3(4):395-8.

31.

Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.

Oliveras-Ferraros C, Cufí S, Queralt B, Vazquez-Martin A, Martin-Castillo B, de Llorens R, Bosch-Barrera J, Brunet J, Menendez JA.

Br J Cancer. 2012 Apr 10;106(8):1406-14. doi: 10.1038/bjc.2012.103.

32.

Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment.

Oliveras-Ferraros C, Massaguer Vall-Llovera A, Vazquez-Martin A, Salip DC, Queralt B, Cufí S, Martin-Castillo B, Bosch-Barrera J, Brunet J, De Llorens R, Menendez JA.

Oncol Rep. 2012 Jun;27(6):1887-92. doi: 10.3892/or.2012.1732. Epub 2012 Mar 15.

PMID:
22427198
33.

Metformin lowers the threshold for stress-induced senescence: a role for the microRNA-200 family and miR-205.

Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Quirantes R, Segura-Carretero A, Micol V, Joven J, Bosch-Barrera J, Del Barco S, Martin-Castillo B, Vellon L, Menendez JA.

Cell Cycle. 2012 Mar 15;11(6):1235-46. doi: 10.4161/cc.11.6.19665. Epub 2012 Mar 15.

PMID:
22356767
34.

AMPK: a bona fide resident of the mitotic spindle midzone.

Menendez JA, Vazquez-Martin A.

Cell Cycle. 2012 Mar 1;11(5):841-2. doi: 10.4161/cc.11.5.19461. Epub 2012 Mar 1. No abstract available.

PMID:
22336917
35.

Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformation.

Oliveras-Ferraros C, Cufí S, Vazquez-Martin A, Menendez OJ, Bosch-Barrera J, Martin-Castillo B, Joven J, Menendez JA.

Cell Cycle. 2012 Mar 1;11(5):865-70. doi: 10.4161/cc.11.5.19252. Epub 2012 Mar 1.

PMID:
22333588
36.

Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.

Vazquez-Martin A, Vellon L, Quirós PM, Cufí S, Ruiz de Galarreta E, Oliveras-Ferraros C, Martin AG, Martin-Castillo B, López-Otín C, Menendez JA.

Cell Cycle. 2012 Mar 1;11(5):974-89. doi: 10.4161/cc.11.5.19450. Epub 2012 Mar 1.

PMID:
22333578
37.

Phenolic secoiridoids in extra virgin olive oil impede fibrogenic and oncogenic epithelial-to-mesenchymal transition: extra virgin olive oil as a source of novel antiaging phytochemicals.

Vazquez-Martin A, Fernández-Arroyo S, Cufí S, Oliveras-Ferraros C, Lozano-Sánchez J, Vellón L, Micol V, Joven J, Segura-Carretero A, Menendez JA.

Rejuvenation Res. 2012 Feb;15(1):3-21. doi: 10.1089/rej.2011.1203. Epub 2012 Jan 9.

38.

Metformin: multi-faceted protection against cancer.

Del Barco S, Vazquez-Martin A, Cufí S, Oliveras-Ferraros C, Bosch-Barrera J, Joven J, Martin-Castillo B, Menendez JA.

Oncotarget. 2011 Dec;2(12):896-917. Review.

39.

Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancer.

Menendez JA, Cufí S, Oliveras-Ferraros C, Martin-Castillo B, Joven J, Vellon L, Vazquez-Martin A.

Aging (Albany NY). 2011 Nov;3(11):1063-77. Review.

40.

Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype.

Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Vellon L, Menendez JA.

Cell Cycle. 2011 Nov 15;10(22):3871-85. doi: 10.4161/cc.10.22.17976. Epub 2011 Nov 15.

PMID:
22127234
41.

mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging.

Menendez JA, Vellon L, Oliveras-Ferraros C, Cufí S, Vazquez-Martin A.

Cell Cycle. 2011 Nov 1;10(21):3658-77. doi: 10.4161/cc.10.21.18128. Epub 2011 Nov 1. Review.

PMID:
22052357
42.

[Prognostic factors and functional imaging in rectal cancer].

García Figueiras R, Caro Domínguez P, García Dorrego R, Vázquez Martín A, Gómez Caamaño A.

Radiologia. 2012 Jan-Feb;54(1):45-58. doi: 10.1016/j.rx.2011.05.017. Epub 2011 Oct 14. Spanish.

43.

Vascular reconstruction of a fusiform basilar aneurysm with the Silk embolization system.

Pumar JM, Garcia-Dorrego R, Nieto A, Vazquez-Herrero F, Blanco-Ulla M, Vazquez-Martin A.

J Neurointerv Surg. 2010 Sep;2(3):242-4. doi: 10.1136/jnis.2010.002725. Epub 2010 Jun 25.

PMID:
21990634
44.

Raptor, a positive regulatory subunit of mTOR complex 1, is a novel phosphoprotein of the rDNA transcription machinery in nucleoli and chromosomal nucleolus organizer regions (NORs).

Vazquez-Martin A, Cufí S, Oliveras-Ferraros C, Menendez JA.

Cell Cycle. 2011 Sep 15;10(18):3140-52. Epub 2011 Sep 15.

PMID:
21900751
45.

Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: a pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models.

Oliveras-Ferraros C, Vazquez-Martin A, Queralt B, Adrados M, Ortiz R, Cufí S, Hernández-Yagüe X, Guardeño R, Báez L, Martin-Castillo B, Pérez-Martínez MC, Lopez-Bonet E, De Llorens R, Bernadó L, Brunet J, Menendez JA.

Int J Oncol. 2011 Dec;39(6):1455-79. doi: 10.3892/ijo.2011.1155. Epub 2011 Aug 9.

PMID:
21833472
46.

Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions.

Vazquez-Martin A, López-Bonetc E, Cufí S, Oliveras-Ferraros C, Del Barco S, Martin-Castillo B, Menendez JA.

Drug Resist Updat. 2011 Aug-Oct;14(4-5):212-23. doi: 10.1016/j.drup.2011.04.003. Epub 2011 May 19.

47.

Metformin activates an ataxia telangiectasia mutated (ATM)/Chk2-regulated DNA damage-like response.

Vazquez-Martin A, Oliveras-Ferraros C, Cufí S, Martin-Castillo B, Menendez JA.

Cell Cycle. 2011 May 1;10(9):1499-501. Epub 2011 May 1. No abstract available.

PMID:
21566461
48.

Gerosuppressant metformin: less is more.

Menendez JA, Cufí S, Oliveras-Ferraros C, Vellon L, Joven J, Vazquez-Martin A.

Aging (Albany NY). 2011 Apr;3(4):348-62. No abstract available.

49.

Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatus.

Vazquez-Martin A, Oliveras-Ferraros C, Cufí S, Menendez JA.

Cell Cycle. 2011 Apr 15;10(8):1295-302. Epub 2011 Apr 15.

PMID:
21474997
50.

Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3.

Oliveras-Ferraros C, Fernández-Arroyo S, Vazquez-Martin A, Lozano-Sánchez J, Cufí S, Joven J, Micol V, Fernández-Gutiérrez A, Segura-Carretero A, Menendez JA.

Int J Oncol. 2011 Jun;38(6):1533-47. doi: 10.3892/ijo.2011.993. Epub 2011 Mar 30.

PMID:
21455577

Supplemental Content

Loading ...
Support Center